Authorised Therapeutic exploratory (Phase II) lateral epicondylitis

MESOTHERAPY IN LATERAL EPICONDYLITIS, A RANDOMIZED, DOUBLE- BLIND STUDY TO COMPARE THE EFFICACY OF MESOTHERAPY WITH PIROXICAM AND LIDOCAINE VERSUS INTRADERMAL DRY NEEDLING, IN THE TREATMENT OF LATERAL EPICONDYLITIS

EU CTIS ID: 2024-519158-34-00

What this study is testing

To assess the efficacy of mesotherapy with intradermal piroxicam and lidocaine delivered in comparison with dry needling for the treatment of lateral epicondylitis (LE).

  • Therapeutic exploratory (Phase II)

A plain-language read of the study's public EU CTIS listing. The study team confirms the details.

Who can take part

You may be able to join if

  • Patients older than 18 years with 1) clinical diagnosis of LE defined as pain over the lateral epicondyle provoked by palpation, resisted extension or gripping; 2) A visual analogue scale (VAS) score for pain greater than 40mm (0-100mm); 3) symptoms duration for more than 3 months.

You likely can't join if

  • 1) other diseases that can alter clinical evaluation detected through history, clinical examination, ultrasound or other exams for comorbidities such as carpal tunnel syndrome, cervical radiculopathy, elbow arthritis, intraarticular loose bodies, previous elbow surgery or clinically significant or recent trauma, fibromyalgia and major psychiatric conditions; 2) VAS score for pain less than 40mm; 3) any of the following treatments during the previous 4 weeks before baseline visit: physical therapy, bandage, mesotherapy and local corticosteroid injection or a combination of these; 4) nonsteroidal anti-inflammatory drugs (NSAIDS) taken during the week previous to inclusion; 5) pregnancy; 6) allergy to any of the study drugs; 7) severely immunosuppressed patients; 8) known coagulopathies.

The study team makes the final eligibility decision.

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.